Hanxiao Chen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Transcription Factor

Small Cell Lung Cancer

Polycystic Ovary Syndrome

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yuling He, Lingdong Kong, Xumeng Ji, Minglei Zhuo, Tongtong An, Bo Jia, Yujia Chi, Jingjing Wang, Jun Zhao, Jianjie Li, Xue Yang, Hanxiao Chen, Xiaoyu Zhai, Yidi Tai, Lu Ding, Ziping Wang, Yuyan Wang
Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival. Thoracic cancer 15 (23) (2024)
Yuling He, Lingdong Kong, Xumeng Ji, Minglei Zhuo, Tongtong An, Bo Jia, Yujia Chi, Jingjing Wang, Jun Zhao, Jianjie Li, Xue Yang, Hanxiao Chen, Xiaoyu Zhai, Yidi Tai, Lu Ding, Ziping Wang, Yuyan Wang
Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival. Thoracic cancer 15 (23) (2024)
Yuling He, Lingdong Kong, Xumeng Ji, Minglei Zhuo, Tongtong An, Bo Jia, Yujia Chi, Jingjing Wang, Jun Zhao, Jianjie Li, Xue Yang, Hanxiao Chen, Xiaoyu Zhai, Yidi Tai, Lu Ding, Ziping Wang, Yuyan Wang
Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival. Thoracic cancer 15 (23) (2024)
Yuling He, Lingdong Kong, Xumeng Ji, Minglei Zhuo, Tongtong An, Bo Jia, Yujia Chi, Jingjing Wang, Jun Zhao, Jianjie Li, Xue Yang, Hanxiao Chen, Xiaoyu Zhai, Yidi Tai, Lu Ding, Ziping Wang, Yuyan Wang
Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival. Thoracic cancer (2024)
Xiaosheng Ding, Weiwei Shi, Bingxuan Han, Hanxiao Chen, Jia Li, Juan An, Lili Zhou, Weiran Xu, Hui Shi, Xixi Zheng, Yichun Hua, Xiao-Yan Li
Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations. Thoracic cancer (2023)
Hanxiao Chen, Jun Zhao
KRAS oncogene may be another target conquered in non-small cell lung cancer (NSCLC). Thoracic cancer 11 (12) (2020)